Stay tuned for #ASCO2026! OPTIMA trial results — including first insights in the premenopausal population — will be presented. These data will contribute to the PATH-FOR-YOUNG / OPTIMA-YOUNG joint analysis on genomic assay–guided chemotherapy de-escalation. #PathForYoung #OptimaYoung